North America Blood Collection Devices Market
North America Blood Collection Devices Market is growing at a CAGR of 6.2% to reach US$ 5,950.62 million by 2030 from US$ 3,688.19 million in 2022 by Product, Methods, and End User

Published On: Jun 2024

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Blood Collection Devices Market

At 6.2% CAGR, North America Blood Collection Devices Market is Projected to be Worth US$ 5,950.62 Million by 2030, says Business Market Insights

 

According to Business Market Insights research, the North America blood collection devices market was valued at US$ 3,688.19 million in 2022 and is expected to reach US$ 5,950.62 million by 2030, registering a CAGR of 6.2% from 2022 to 2030. Technological developments in blood collection techniques & products and rising incidences of chronic diseases are among the critical factor attributed to the North America blood collection devices market expansion.

Collecting blood from patients with difficult venous access (DVA) is challenging. In the case of DVA patients, the traditionally used blood collection device is often unable to collect adequate samples; this might lead to repeated attempts to collect blood. The risk of anemia can arise due to these repeated attempts and the risk of transmission of blood-borne pathogens to nurses. To avoid such scenarios, market players have launched innovative hematology-tube designs that support capillary blood collection while reducing the risks of blood collection and treatment errors in DVA patients. The new technology offers a painless, needle-free, easy-to-use technique for collecting blood samples. The system allows blood samples to be taken in a nominally invasive manner. Once placed on a patient’s upper arm, hematology-tube improves capillary blood flow beneath the skin through micro-incision and patented skin vasodilation technology.

On the contrary, risk associated with needlestick injuries hampers the growth of North America blood collection devices market.

Based on product type, the North America blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held 33.0% share of North America blood collection devices market in 2022, amassing US$ 1,216.34 million. It is projected to garner US$ 2,079.55 million by 2030 to expand at 6.9% CAGR during 2022–2030.

In terms of methods, the North America blood collection devices market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held 83.4% share of North America blood collection devices market in 2022, amassing US$ 3,075.49 million. It is projected to garner US$ 4,917.40 million by 2030 to expand at 6.0% CAGR during 2022–2030.

By end user, the North America blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held 58.3% share of North America blood collection devices market in 2022, amassing US$ 2,151.60 million. It is projected to garner US$ 3,508.04 million by 2030 to expand at 6.3% CAGR during 2022–2030.

Based on country, the North America blood collection devices market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 75.5% share of North America blood collection devices market in 2022. It was assessed at US$ 2,784.08 million in 2022 and is likely to hit US$ 4,515.91 million by 2030, exhibiting a CAGR of 6.2% during 2022–2030.

Key players operating in the North America blood collection devices market are Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH, among others.

  • In Octobers 2022, BD and Magnolia Medical Technologies Inc announced a commercial agreement aimed at helping the US hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.
  • In May 2022, Terumo Blood and Cell Technologies inaugurated its manufacturing facility in Douglas County, Colorado. Terumo Blood and Cell Technologies is a medical technology company specializing in a portfolio of products, software and services for blood component collection, therapeutic apheresis and cellular technologies.

 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com